NEW YORK (GenomeWeb) – NantHealth announced on Wednesday that it has received a $250 million investment from the Kuwait Investment Authority and has named new members to its management team.

The Los Angeles-based firm is part of the NantWorks group of companies, is developing a cloud-based, single healthcare management platform that aims to provide genomic and proteomic data at the patient level and integrate such data with information about therapies, clinical trials, and scientific research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.